FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075896532> ?p ?o ?g. }

• W2075896532 endingPage "462" @default.
• W2075896532 startingPage "454" @default.
• W2075896532 abstract "Cancer chemotherapy is hampered by serious toxicity to healthy tissues. Conceivably, encapsulation of cytotoxic drugs in actively targeted, biocompatible nanocarriers could overcome this problem. Accordingly, we used sterically stabilized mixed micelles (SSMM) composed of biocompatible and biodegradable phospholipids to solubilize paclitaxel (P), a hydrophobic model cytotoxic drug, and deliver it to breast cancer in rats. To achieve active targeting, the surface of SSMM was grafted with a ligand, human vasoactive intestinal peptide (VIP) that selectively interacts with its cognate receptors overexpressed on breast cancer cells. We found that even in vitro cytotoxicity of P-SSMM-VIP was 2-fold higher that that of free paclitaxel (p < 0.05). Given the unique attributes of P-SSMM and P-SSMM-VIP, most notable small hydrodynamic diameter (∼15 nm) and stealth properties, biodistribution of paclitaxel was significantly altered. Accumulation of paclitaxel in breast tumor was highest for P-SSMM-VIP, followed by P-SSMM and Cremophor-based paclitaxel (PTX). Importantly, bone marrow accumulation of paclitaxel encapsulated in both SSMM-VIP and SSMM was significantly less than that of PTX. Administration of clinically relevant dose of paclitaxel (5 mg/kg) as P-SSMM-VIP and P-SSMM eradicated carcinogen-induced orthotopic breast cancer in rats, whereas PTX decreased tumor size by only 45 %. In addition, a 5-fold lower dose (1 mg/kg) of paclitaxel in actively targeted P-SSMM-VIP was associated with ∼80 % reduction in tumor size while the response to PTX and P-SSMM was significantly less. Hypotension was not observed when VIP was grafted onto SSMM. Based on our findings, we propose further development of effective and safe VIP-grafted phospholipid micelle nanomedicines of anti-cancer drugs for targeted treatment of solid tumors in humans." @default.
• W2075896532 created "2016-06-24" @default.
• W2075896532 creator A5004947609 @default.
• W2075896532 creator A5017271794 @default.
• W2075896532 creator A5027340772 @default.
• W2075896532 creator A5028700223 @default.
• W2075896532 creator A5088386011 @default.
• W2075896532 date "2012-10-12" @default.
• W2075896532 modified "2023-09-27" @default.
• W2075896532 title "VIP-targeted cytotoxic nanomedicine for breast cancer" @default.
• W2075896532 cites W1588092478 @default.
• W2075896532 cites W166486881 @default.
• W2075896532 cites W1829954519 @default.
• W2075896532 cites W1964317189 @default.
• W2075896532 cites W1968639572 @default.
• W2075896532 cites W1976041621 @default.
• W2075896532 cites W1981551573 @default.
• W2075896532 cites W1982974605 @default.
• W2075896532 cites W1984868072 @default.
• W2075896532 cites W1999918836 @default.
• W2075896532 cites W2001684619 @default.
• W2075896532 cites W2005926362 @default.
• W2075896532 cites W2011476580 @default.
• W2075896532 cites W2016528090 @default.
• W2075896532 cites W2018559365 @default.
• W2075896532 cites W2021470807 @default.
• W2075896532 cites W2032395145 @default.
• W2075896532 cites W2033702281 @default.
• W2075896532 cites W2035843561 @default.
• W2075896532 cites W2036587772 @default.
• W2075896532 cites W2038742533 @default.
• W2075896532 cites W2039539621 @default.
• W2075896532 cites W2039911974 @default.
• W2075896532 cites W2042249858 @default.
• W2075896532 cites W2046308571 @default.
• W2075896532 cites W2056546949 @default.
• W2075896532 cites W2067490217 @default.
• W2075896532 cites W2070157064 @default.
• W2075896532 cites W2071457099 @default.
• W2075896532 cites W2076614074 @default.
• W2075896532 cites W2078279342 @default.
• W2075896532 cites W2080991351 @default.
• W2075896532 cites W2085038583 @default.
• W2075896532 cites W2085824066 @default.
• W2075896532 cites W2090323004 @default.
• W2075896532 cites W2094129747 @default.
• W2075896532 cites W2124808968 @default.
• W2075896532 cites W2143992183 @default.
• W2075896532 cites W2144872934 @default.
• W2075896532 cites W2165732324 @default.
• W2075896532 cites W2334684541 @default.
• W2075896532 doi "https://doi.org/10.1007/s13346-012-0107-x" @default.
• W2075896532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3546828" @default.
• W2075896532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23336096" @default.
• W2075896532 hasPublicationYear "2012" @default.
• W2075896532 type Work @default.
• W2075896532 sameAs 2075896532 @default.
• W2075896532 citedByCount "23" @default.
• W2075896532 countsByYear W20758965322013 @default.
• W2075896532 countsByYear W20758965322014 @default.
• W2075896532 countsByYear W20758965322016 @default.
• W2075896532 countsByYear W20758965322017 @default.
• W2075896532 countsByYear W20758965322018 @default.
• W2075896532 countsByYear W20758965322019 @default.
• W2075896532 countsByYear W20758965322020 @default.
• W2075896532 countsByYear W20758965322021 @default.
• W2075896532 countsByYear W20758965322022 @default.
• W2075896532 crossrefType "journal-article" @default.
• W2075896532 hasAuthorship W2075896532A5004947609 @default.
• W2075896532 hasAuthorship W2075896532A5017271794 @default.
• W2075896532 hasAuthorship W2075896532A5027340772 @default.
• W2075896532 hasAuthorship W2075896532A5028700223 @default.
• W2075896532 hasAuthorship W2075896532A5088386011 @default.
• W2075896532 hasBestOaLocation W20758965322 @default.
• W2075896532 hasConcept C109316439 @default.
• W2075896532 hasConcept C121608353 @default.
• W2075896532 hasConcept C126322002 @default.
• W2075896532 hasConcept C15083742 @default.
• W2075896532 hasConcept C154317977 @default.
• W2075896532 hasConcept C155672457 @default.
• W2075896532 hasConcept C171250308 @default.
• W2075896532 hasConcept C18150654 @default.
• W2075896532 hasConcept C185592680 @default.
• W2075896532 hasConcept C192562407 @default.
• W2075896532 hasConcept C202751555 @default.
• W2075896532 hasConcept C2776694085 @default.
• W2075896532 hasConcept C2777292972 @default.
• W2075896532 hasConcept C2777511904 @default.
• W2075896532 hasConcept C2777807558 @default.
• W2075896532 hasConcept C2780035454 @default.
• W2075896532 hasConcept C502942594 @default.
• W2075896532 hasConcept C530470458 @default.
• W2075896532 hasConcept C55493867 @default.
• W2075896532 hasConcept C71924100 @default.
• W2075896532 hasConcept C98274493 @default.
• W2075896532 hasConceptScore W2075896532C109316439 @default.
• W2075896532 hasConceptScore W2075896532C121608353 @default.
• W2075896532 hasConceptScore W2075896532C126322002 @default.

• next